Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) FCF Margin (2024 - 2025)

Indivior Pharmaceuticals has reported FCF Margin over the past 2 years, most recently at 68.44% for Q4 2025.

  • Quarterly results put FCF Margin at 68.44% for Q4 2025, down 5740.0% from a year ago — trailing twelve months through Dec 2025 was 7.5% (down 809.0% YoY), and the annual figure for FY2025 was 7.51%, down 810.0%.
  • FCF Margin for Q4 2025 was 68.44% at Indivior Pharmaceuticals, down from 18.79% in the prior quarter.
  • Over the last five years, FCF Margin for INDV hit a ceiling of 46.69% in Q2 2025 and a floor of 68.44% in Q4 2025.